Deaths from viral hepatitis surpasses HIV/AIDS as preventable cause of deaths in Australia

April 17, 2014

The analysis was conducted by Dr Benjamin Cowie and Ms Jennifer MacLachlan from the University of Melbourne and Melbourne Health, and was presented at The International Liver Congress in London earlier this month.

"Liver cancer is the fastest increasing cause of cancer deaths in Australia, increasing each year by 5 per cent, so by more than seventy people each year. In 2014 there was an estimated number of deaths of around 1,500 from liver cancer. The predominant cause is chronic viral Hepatitis," Dr Cowie said.

Hepatitis refers to the inflammation of the liver. Chronic infection with the blood-borne viruses Hepatitis B or Hepatitis C can result in scarring of the liver (cirrhosis) or potentially at a later stage – however these risks can be reduced through access to effective care and treatment.

Dr Cowie said additional resources were needed to prevent and treat Hepatitis B and C in order to address these imbalances in major preventable causes of human death.

"The release of the GBD 2010 results provides a unique opportunity to set global and local priorities for health, and address previous imbalances in addressing the major causes of preventable causes of human death, among which hepatitis B and C must clearly be counted."

"The Commonwealth Government has recently committed to funding initiatives to improve access to testing and treatment for people from priority populations living with B in Australia, which is a great step forward," he said.

"The Global Burden of Disease (GBD) estimated around 1.3 million people lost their lives to viral Hepatitis since 1990, which is comparable to the respective burdens of HIV/AIDS, tuberculosis and malaria," Dr Cowie concluded.

Explore further: Viral hepatitis more deadly than HIV in Europe

Related Stories

Viral hepatitis more deadly than HIV in Europe

April 11, 2014
Mortality from viral hepatitis is significantly higher than from HIV/AIDS across EU countries, according to results from The Global Burden of Disease Study 2010 (GBD 2010) which was announced for the first time today at the ...

Hepatitis C remains major problem for HIV patients despite antiretroviral therapy

March 17, 2014
A new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania has found that the risk of hepatitis C-associated serious liver disease persists in HIV patients otherwise benefitting from ...

Coffee consumption reduces mortality risk from liver cirrhosis

April 2, 2014
New research reveals that consuming two or more cups of coffee each day reduces the risk of death from liver cirrhosis by 66%, specifically cirrhosis caused by non-viral hepatitis. Findings in Hepatology, a journal published ...

Hepatitis B screening proposed for all high-risk adults

February 11, 2014
(HealthDay)—Adults at high risk for hepatitis B should be screened for the viral infection, according to a draft recommendation from the U.S. Preventive Services Task Force.

Gene variants protect against relapse after treatment for hepatitis C

March 13, 2014
Researchers at the Sahlgrenska Academy, University of Gothenburg, have identified a gene, which explains why certain patients with chronic hepatitis C do not experience relapse after treatment. The discovery may contribute ...

New data reveals positive outcomes for hepatitis C transplant patients

April 11, 2014
New research announced at the International Liver Congress 2014 today provides new hope for the notoriously difficult-to-treat population of liver transplant patients with recurring hepatitis C (HCV).

Recommended for you

Three-in-one antibody protects monkeys from HIV-like virus

September 20, 2017
A three-pronged antibody made in the laboratory protected monkeys from infection with two strains of SHIV, a monkey form of HIV, better than individual natural antibodies from which the engineered antibody is derived, researchers ...

Fighting HIV on multiple fronts might lead to vaccine

September 20, 2017
A combination antibody strategy could be the key to halting the spread of HIV, according to results from two promising animal studies.

HIV-AIDS: Following your gut

September 18, 2017
Researchers at the University of Montreal Hospital Research Centre (CRCHUM) have discovered a way to slow viral replication in the gastrointestinal tract of people infected by HIV-AIDS.

Study finds cutbacks in foreign aid for HIV treatment would cause great harm

August 30, 2017
Proposed reductions in U.S. foreign aid would have a devastating impact on HIV treatment and prevention programs in countries receiving such aid, an international team of investigators reports. In their paper published online ...

Cancer drug can reactivate HIV

August 24, 2017
People living with HIV must take a combination of three or more different drugs every day for the rest of their lives. Unfortunately, by following this strict treatment plan, they can suffer from side effects ranging from ...

New injectable antiretroviral treatment proved to be as effective as standard oral therapy

August 3, 2017
Intramuscularly administered antiretroviral therapy (ART) may be as effective for HIV treatment as current oral therapies. This is the main conclusion of a Phase II clinical trial carried out by 50 research centers around ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.